13F-HR filed by Altium Capital Management LLC
Altium Capital Management LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-09, with 24 holding rows worth $43,789,879.
- Accession
- 0001420506-25-000948
- Filer
- CIK 1746382
- Filed
- 2025-05-09
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 24 entries on the cover page, a total value of $43,789,879 stated on the cover page (in dollars after the unit check, H1), rows summing to $43,789,879 with VALUE read as dollars as filed, 13F file number 028-20820. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 1,287,333 | $9,642,124 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 25,000 | $6,750,500 | dollars as filed | put |
| EVOLUS INC | 30052C107 | COM | 296,193 | $3,563,202 | dollars as filed | |
| XTANT MED HLDGS INC | 98420P308 | COM NEW | 7,252,998 | $3,408,909 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 419,131 | $3,281,796 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 303,857 | $2,120,922 | dollars as filed | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 360,589 | $2,098,628 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 60,251 | $2,021,421 | dollars as filed | |
| LOGICMARK INC | 67091J602 | COM NEW | 98,325,683 | $1,946,849 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 1,050,369 | $1,659,583 | dollars as filed | |
| SKYE BIOSCIENCE INC | 83086J200 | COM NEW | 904,865 | $1,438,735 | dollars as filed | |
| ALPHA COGNITION INC | 02074J501 | COM NEW | 177,416 | $897,725 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 303,949 | $881,452 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 1,051,379 | $714,938 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 168,589 | $613,664 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 273,204 | $587,389 | dollars as filed | |
| SHARPS TECHNOLOGY INC | 82003F200 | COM NEW | 18,737,471 | $560,250 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M406 | COM NEW | 574,248 | $399,389 | dollars as filed | |
| ENVVENO MEDICAL CORPORATION | 29415J106 | COM | 123,256 | $324,163 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 9,400 | $315,370 | dollars as filed | call |
| INTELLIGENT BIO SOLUTIONS IN | 36151G600 | COM | 149,252 | $214,923 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 49,333 | $184,505 | dollars as filed | |
| SUNSHINE BIOPHARMA INC | 867781700 | COM | 50,466 | $96,390 | dollars as filed | |
| SRX GLOBAL INC | 08771Y402 | COM NEW | 38,984 | $67,052 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-000948 | this filing | 2025-05-09 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001420506-25-000988 | base | 2025-05-13 | acceptance time not in the bulk data set |